Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Role of Reactive Thrombocytosis in Children With Pneumococcal Infection

This study has been completed.
Sponsor:
Collaborator:
University of Alberta
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01194349
First received: August 31, 2010
Last updated: September 1, 2010
Last verified: May 2010
  Purpose

Thrombocytosis, mostly reactive in nature, is common in pediatric hospitalized patients with infections. Streptococcus pneumoniae (S. Pneumoniae) is the most common pathogen. In this study, the investigators investigated the associations of clinical profiles and thrombocytosis and evaluated platelet counts, leukocyte counts and CRP levels as predictors of hospitalization days in patients with S. pneumoniae infection.


Condition
Thrombocytosis
S. Pneumoniae Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: The Role of Reactive Thrombocytosis in Children With Pneumococcal Infection

Resource links provided by NLM:


Further study details as provided by Taipei Medical University WanFang Hospital:

  Eligibility

Ages Eligible for Study:   1 Year to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pediatric hospitalized patients less than 18 year-old.

Criteria

Inclusion Criteria:

  • Pediatric patients diagnosed with pneumococcal infection.

Exclusion Criteria:

  • Patients with automatic discharge.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01194349

Locations
Taiwan
Jinn-Li Wang
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
University of Alberta
  More Information

No publications provided

Responsible Party: Department of Pediatrics, WanFang Hospital, Department of Pediatrics
ClinicalTrials.gov Identifier: NCT01194349     History of Changes
Other Study ID Numbers: WFH-PED 001, Version 2.990526
Study First Received: August 31, 2010
Last Updated: September 1, 2010
Health Authority: Taiwan: Department of Health

Keywords provided by Taipei Medical University WanFang Hospital:
S. pneumoniae
thrombocytosis
pediatric patients
The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection

Additional relevant MeSH terms:
Communicable Diseases
Infection
Pneumococcal Infections
Pneumonia
Thrombocytosis
Bacterial Infections
Blood Platelet Disorders
Bone Marrow Diseases
Gram-Positive Bacterial Infections
Hematologic Diseases
Lung Diseases
Myeloproliferative Disorders
Respiratory Tract Diseases
Respiratory Tract Infections
Streptococcal Infections

ClinicalTrials.gov processed this record on November 23, 2014